⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Axis Midcap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Axis MF | HDFC MF |
| Category | Equity - Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹137.04 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | BSE 150 MidCap - TRI | BSE Health Care - TRI |
| Fund Manager | Shreyash Devalkar | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | 1.55% | 22.64% |
| 3Y | 16.26% | 30.41% |
| 5Y | 11.96% | — |
| Since Inception | 18.12% | 29.15% |
| Risk | ||
| 15.14 | 14.07 | |
| 1.00 | 0.59 | |
| 0.64 | 1.59 | |
| 9.40 | 21.67 | |
| 1.22 | 3.48 | |
| -11.29% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.84% | 1.03% |
| Exit Load | Nil for 10% of investments and 1% for remaining investments on or before 3M, Nil after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Axis MF98%
HDFC MF98%
2.3%Only 2.3% of holdings by weight are common between Axis MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingAxis MFHDFC MF
Ipca Laboratories Ltd.2.30%2.98%
Category context: Equity vs Equity. Open the full Screener →